Super‑Startup Squad vs. COVID‑19
Rise the tech‑savvy entrepreneurs, each armed with cutting‑edge tools and a punch‑bag of cash, ready to wage war on the invisible villain SARS‑CoV‑2.
Top 5 fundraising champs
According to AksjeBloggen’s latest intel, these five North American marvels raked in a $433.2 million windfall during the pandemic.
- Ro (New York‑based healthcare tech) grabbed the lion’s share: $176.1 million – its $433.2 million total funding crown it as the headline–holder for COVID check‑ups.
- Nurx, the San Francisco startup pulling the digital threads, tallied $93.4 million over six funding rounds, the latest being a Series C in August 2019.
- Carbon Health pulled in a tidy $72.5 million, with its most recent $28 million boost from Data Collective DCVC back in May.
- EverlyWell, the Austin‑based pioneer, raised $50 million, empowering patients to nail home tests for everything from food sensitivities to STDs.
What the apps are doing
Ro rolled out a free digital symptom assessment. If the red flag shows up, the system connects users with a doctor via a video call.
Nurx, EverlyWell, and Carbon are all pushing at‑home testing into the mainstream, offering mail‑ordered COVID kits across the United States.
Carbon’s latest Series B round gave it the juice to expand both in‑clinic and at‑home services, promising a faster, seamless healthcare experience for everyone.
The AI-based solutions for fighting coronavirus
Metabiota: The Pandemic Whisperer
Picture a San Francisco startup that’s the fifth most‑funded company on the list and, to be honest, the only software‑centric aliens among the AI galaxy. That’s Metabiota for you.
Funding Stack
They’ve swept up a tidy $41.2 million over four rounds. If money were a pandemic, that would be a four‑tier cluster‑infection‑free system.
What They Do (Really)
Metabiota isn’t just “playing with data.” They are the heroes behind comprehensive risk analytics that help governments manage and mitigate infectious diseases before the world turns into a fevered nightmare.
February Forecast—The World’s Risky List
- China
- Japan
- Italy
- Iran
- South Korea
- Thailand
- United States
- Taiwan
- Australia
- Philippines
They called them “at‑risk” with the kind of foresight that would make your grandmother’s superstitions look like a walk in the park.
Why It Matters—And a Little Humor
Because if we’ve learned anything from the last two years, it’s that data in a honey‑sweet notebook can keep us from getting stuck in a 2023‑style quarantine of “guess‑and‑hope kits.” Metabiota’s charts give the world something better to swipe—smart decisions, not just finger‑wagging.
Fun Fact: The team’s motto? “We predict pandemics, not cocktail recipes.” (Seriously, that’s how you keep the COVID‑19 jokes at bay.)
